WINDTREE THERAPEUTICS INC /DE/ Basic Shares Outstanding (Weighted Average)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Basic Shares Outstanding (Weighted Average) of 26.68 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 26.68M shares, a 150269.55% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 4.88M shares, a 42322.00% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 1.09B shares, a 11611.29% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for the quarter ending 2024-12-31 was 210.29M shares, a 1163.86% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for fiscal 2024 was 52.58M shares, a 1122.86% increase from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for fiscal 2023 was 4.30M shares, a 582.54% increase from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for fiscal 2022 was 630.00K shares, a 27.27% increase from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic for fiscal 2021 was 495.00K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 26.68M shares 10-Q · filed 2025-11-19 | 15.78M shares derived: average of 2 quarters · filed 2025-11-19 | 10.97M shares 10-Q · filed 2025-11-19 | 332.60M shares derived: average of 4 quarters · filed 2025-11-19 | ||||
| 2025-06-30 | 4.88M shares 10-Q · filed 2025-08-19 | 2.99M shares 10-Q · filed 2025-08-19 | 434.58M shares derived: average of 3 quarters · filed 2025-08-19 | 325.94M shares derived: average of 4 quarters · filed 2025-11-19 | ||||
| 2025-03-31 | 1.09B shares 10-Q · filed 2025-05-15 | 649.43M shares derived: average of 2 quarters · filed 2025-05-15 | 432.96M shares derived: average of 3 quarters · filed 2025-11-19 | 324.72M shares derived: average of 4 quarters · filed 2025-11-19 | ||||
| 2024-12-31 | 210.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 105.16M shares derived: average of 2 quarters · filed 2025-11-19 | 70.11M shares derived: average of 3 quarters · filed 2025-11-19 | 52.58M shares 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | 17.74K shares 10-Q · filed 2025-11-19 | 887.00K shares 10-Q · filed 2024-11-26 | 14.62K shares derived: average of 2 quarters · filed 2025-11-19 | 12.86K shares 10-Q · filed 2025-11-19 | 643.00K shares 10-Q · filed 2024-11-26 | 6.49M shares derived: average of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | 11.50K shares 10-Q · filed 2025-08-19 | 575.00K shares 10-Q · filed 2024-08-19 | 10.40K shares 10-Q · filed 2025-08-19 | 520.00K shares 10-Q · filed 2024-08-19 | 8.65M shares derived: average of 3 quarters · filed 2025-08-19 | 6.56M shares derived: average of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | 9.29M shares 10-Q · filed 2025-05-15 | 465.00K shares 10-Q · filed 2024-05-15 | 12.97M shares derived: average of 2 quarters · filed 2025-05-15 | 8.74M shares derived: average of 3 quarters · filed 2025-05-15 | 6.61M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 16.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 8.46M shares derived: average of 2 quarters · filed 2025-04-15 | 5.72M shares derived: average of 3 quarters · filed 2025-04-15 | 4.30M shares 10-K · filed 2025-04-15 | 3.88M shares 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 286.00K shares 10-Q · filed 2024-11-26 | 5.15M shares 10-Q · filed 2023-11-09 | 255.00K shares derived: average of 2 quarters · filed 2024-11-26 | 187.00K shares 10-Q · filed 2024-11-26 | 3.36M shares 10-Q · filed 2023-11-09 | 326.25K shares derived: average of 4 quarters · filed 2024-11-26 | ||
| 2023-06-30 | 224.00K shares 10-Q · filed 2024-08-19 | 4.03M shares 10-Q · filed 2023-08-07 | 136.00K shares 10-Q · filed 2024-08-19 | 2.46M shares 10-Q · filed 2023-08-07 | 339.67K shares derived: average of 3 quarters · filed 2024-08-19 | 410.50K shares derived: average of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | 48.00K shares 10-Q · filed 2024-05-15 | 863.00K shares 10-Q · filed 2023-05-15 | 397.50K shares derived: average of 2 quarters · filed 2024-05-15 | 472.67K shares derived: average of 3 quarters · filed 2024-05-15 | 500.50K shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 747.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 685.00K shares derived: average of 2 quarters · filed 2024-04-16 | 651.33K shares derived: average of 3 quarters · filed 2024-04-16 | 630.00K shares 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | 623.00K shares 10-Q · filed 2023-11-09 | 31.14M shares 10-Q · filed 2022-11-14 | 603.50K shares derived: average of 2 quarters · filed 2023-11-09 | 591.00K shares 10-Q · filed 2023-11-09 | 29.55M shares 10-Q · filed 2022-11-14 | -16.77M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 584.00K shares 10-Q · filed 2023-08-07 | 29.20M shares 10-Q · filed 2022-08-11 | 575.00K shares 10-Q · filed 2023-08-07 | 29.24M shares 10-Q · filed 2022-08-11 | -22.57M shares derived: average of 3 quarters · filed 2023-08-07 | -10.25M shares derived: average of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | 566.00K shares 10-Q · filed 2023-05-15 | 28.30M shares 10-Q · filed 2022-05-05 | -34.15M shares derived: average of 2 quarters · filed 2023-05-15 | -13.87M shares derived: average of 3 quarters · filed 2023-05-15 | -3.81M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -68.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -21.08M shares derived: average of 2 quarters · filed 2023-03-31 | -5.27M shares derived: average of 3 quarters · filed 2023-03-31 | 495.00K shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 26.70M shares 10-Q · filed 2022-11-14 | 26.53M shares derived: average of 2 quarters · filed 2022-11-14 | 23.62M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 26.35M shares 10-Q · filed 2022-08-11 | 22.05M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 17.70M shares 10-Q · filed 2022-05-05 | |||||||
| 2018-12-31 | 7.19M shares 10-K/A · filed 2019-04-23 | 5.48M shares derived: average of 2 quarters · filed 2019-04-23 | 4.90M shares derived: average of 3 quarters · filed 2019-04-23 | 4.49M shares 10-K/A · filed 2019-04-23 | ||||
| 2018-09-30 | 3.77M shares 10-K/A · filed 2019-04-23 | 3.76M shares derived: average of 2 quarters · filed 2019-04-23 | 3.58M shares derived: average of 3 quarters · filed 2019-04-23 | 3.29M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2018-06-30 | 3.75M shares 10-K/A · filed 2019-04-23 | 3.49M shares derived: average of 2 quarters · filed 2019-04-23 | 3.13M shares derived: average of 3 quarters · filed 2019-04-23 | 2.53M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2018-03-31 | 3.23M shares 10-K/A · filed 2019-04-23 | 2.82M shares derived: average of 2 quarters · filed 2019-04-23 | 2.12M shares derived: average of 3 quarters · filed 2019-04-23 | 1.72M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2017-12-31 | 2.40M shares 10-K/A · filed 2019-04-23 | 1.57M shares derived: average of 2 quarters · filed 2019-04-23 | 1.21M shares derived: average of 3 quarters · filed 2019-04-23 | 1.03M shares 10-K/A · filed 2019-04-23 | ||||
| 2017-09-30 | 729.00K shares 10-K/A · filed 2019-04-23 | 618.00K shares derived: average of 2 quarters · filed 2019-04-23 | 562.00K shares derived: average of 3 quarters · filed 2019-04-23 | 2.55M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2017-06-30 | 507.00K shares 10-K/A · filed 2019-04-23 | 478.50K shares derived: average of 2 quarters · filed 2019-04-23 | 3.16M shares derived: average of 3 quarters · filed 2019-04-23 | 4.46M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2017-03-31 | 450.00K shares 10-K/A · filed 2019-04-23 | 4.49M shares derived: average of 2 quarters · filed 2019-04-23 | 5.78M shares derived: average of 3 quarters · filed 2019-04-23 | 6.39M shares derived: average of 4 quarters · filed 2019-04-23 | ||||
| 2016-12-31 | 8.52M shares 10-K · filed 2017-03-31 | 8.44M shares derived: average of 2 quarters · filed 2017-03-31 | 8.37M shares derived: average of 3 quarters · filed 2017-03-31 | 8.33M shares 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | 8.36M shares 10-K · filed 2017-03-31 | 8.30M shares derived: average of 2 quarters · filed 2017-03-31 | 8.26M shares derived: average of 3 quarters · filed 2017-03-31 | 8.21M shares derived: average of 4 quarters · filed 2017-03-31 | ||||
| 2016-06-30 | 8.24M shares 10-K · filed 2017-03-31 | 8.21M shares derived: average of 2 quarters · filed 2017-03-31 | 8.16M shares derived: average of 3 quarters · filed 2017-03-31 | 8.01M shares derived: average of 4 quarters · filed 2017-03-31 | ||||
| 2016-03-31 | 8.19M shares 10-K · filed 2017-03-31 | 8.12M shares derived: average of 2 quarters · filed 2017-03-31 | 7.93M shares derived: average of 3 quarters · filed 2017-03-31 | 7.48M shares derived: average of 4 quarters · filed 2017-03-31 | ||||
| 2015-12-31 | 8.05M shares 10-K · filed 2017-03-31 | 7.80M shares derived: average of 2 quarters · filed 2017-03-31 | 7.24M shares derived: average of 3 quarters · filed 2017-03-31 | 6.97M shares 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | 7.55M shares 10-K · filed 2017-03-31 | 105.70M shares 10-Q · filed 2015-11-05 | 6.84M shares derived: average of 2 quarters · filed 2017-03-31 | 92.42M shares 10-Q · filed 2015-11-05 | 6.47M shares derived: average of 4 quarters · filed 2017-03-31 | |||
| 2015-06-30 | 6.13M shares 10-K · filed 2017-03-31 | 85.75M shares 10-Q · filed 2015-08-10 | 85.67M shares 10-Q · filed 2015-08-10 | 6.11M shares derived: average of 3 quarters · filed 2017-03-31 | 6.11M shares derived: average of 4 quarters · filed 2017-03-31 | |||
| 2015-03-31 | 6.11M shares 10-K · filed 2017-03-31 | 6.11M shares derived: average of 2 quarters · filed 2017-03-31 | 6.10M shares derived: average of 3 quarters · filed 2017-03-31 | 6.09M shares derived: average of 4 quarters · filed 2017-03-31 | ||||
| 2014-12-31 | 6.10M shares 10-K · filed 2016-03-29 | 85.36M shares 10-K · filed 2015-03-16 | 6.09M shares derived: average of 2 quarters · filed 2016-03-29 | 6.09M shares derived: average of 3 quarters · filed 2016-03-29 | 6.08M shares 10-K · filed 2016-03-29 | 85.09M shares 10-K · filed 2015-03-16 | ||
| 2014-09-30 | 6.09M shares 10-K · filed 2016-03-29 | 85.21M shares 10-Q · filed 2014-11-07 | 6.08M shares derived: average of 2 quarters · filed 2016-03-29 | 85.00M shares 10-Q · filed 2015-11-05 | 22.84M shares derived: average of 4 quarters · filed 2016-03-29 | |||
| 2014-06-30 | 6.08M shares 10-K · filed 2016-03-29 | 85.06M shares 10-Q · filed 2014-08-07 | 84.77M shares 10-Q · filed 2015-08-10 | 28.42M shares derived: average of 3 quarters · filed 2016-03-29 | 35.01M shares derived: average of 4 quarters · filed 2016-03-29 | |||
| 2014-03-31 | 6.05M shares 10-K · filed 2016-03-29 | 84.73M shares 10-K · filed 2015-03-16 | 39.59M shares derived: average of 2 quarters · filed 2016-03-29 | 44.66M shares derived: average of 3 quarters · filed 2016-03-29 | 45.78M shares derived: average of 4 quarters · filed 2016-03-29 | |||
| 2013-12-31 | 73.13M shares 10-K · filed 2015-03-16 | 63.96M shares derived: average of 2 quarters · filed 2015-03-16 | 59.02M shares derived: average of 3 quarters · filed 2015-03-16 | 55.26M shares 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | 54.79M shares 10-K · filed 2015-03-16 | 51.96M shares derived: average of 2 quarters · filed 2015-03-16 | 49.23M shares 10-Q · filed 2014-11-07 | 47.75M shares derived: average of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | 49.13M shares 10-K · filed 2015-03-16 | 46.41M shares 10-Q · filed 2014-08-07 | 45.40M shares derived: average of 3 quarters · filed 2015-03-16 | 44.91M shares derived: average of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | 43.66M shares 10-K · filed 2015-03-16 | 43.53M shares derived: average of 2 quarters · filed 2015-03-16 | 43.50M shares derived: average of 3 quarters · filed 2015-03-16 | 43.47M shares derived: average of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | 43.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 43.42M shares derived: average of 2 quarters · filed 2015-03-16 | 43.40M shares derived: average of 3 quarters · filed 2015-03-16 | 39.40M shares 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | 43.44M shares 10-Q · filed 2013-11-12 | 43.41M shares derived: average of 2 quarters · filed 2013-11-12 | 38.06M shares 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | 43.37M shares 10-Q · filed 2013-08-08 | 35.33M shares 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |